Brian Coggio Published in Biotechnology Law Report

Authors

Name

Brian D. Coggio

Person title

Of Counsel

Brian Coggio was recently published in the Biotechnology Law Report with an article titled, “Inter Partes Review by Hatch-Waxman Competitors Will Likely Increase Because of the Effect of IPR Decisions on the 30-Month Stay.” Coggio discusses the Hatch-Waxman Act, the 30-Month Stay, and pertinent decisions by the United States Patent and Trademark Office and the Patent Trial and Appeal Board. Read the full article here.

The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.

Brian Coggio Published in Biotechnology Law Report

Authors

Federal Circuit to Consider the Relevance of an Alleged Infringer’s “Intent” in a Hatch-Waxman Safe Harbor Analysis

Fish Attorneys Author IP Litigator Article, "Regenxbio v. Sarepta: Make Sure You're Safely Within the Safe Harbor Before Using a 'Research Tool'"

REGENXBIO v. SAREPTA: Make Sure You're Safely Within the Safe Harbor Before Using a "Research Tool"

Users of Research Tools Take Note

Attorneys for Branded Companies Should Carefully Review ANDAs for Admissions Regarding Generic Infringement

First Circuit Finds Device Patent Improperly Listed in the Orange Book

Generic Drug Labeling and Induced Patent Infringement

Prodrugs — Federal Circuit Holds That A PTE Does Not Cover Their Metabolites

Potential Ways for Avoiding the Presumption of Prosecution History Estoppel of an Allowable Dependent Claim Depending from a Rejected Independent Claim

Ensnarement Defense To Doctrine of Equivalents Succeeds On Summary Judgment

Hatch-Waxman 101

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments

ITC Monthly Wrap-Up: February 2024

ITC Monthly Wrap-Up: January 2024

Texas Patent Litigation Monthly Wrap-Up: December 2023

Hatch-Waxman 2023 Year in Review

Middle District of North Carolina Finds Public Interest Favors Granting Preliminary Injunction

ITC Monthly Wrap-Up: December 2023

The Federal Circuit Weighs in On Hatch-Waxman “Skinny” Label Infringement Dispute

Legal Alert: Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices